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Summary 
 
Background: Clostridium difficile infections are common among hospitalised patients, 
with some infections acquired in hospital and others in the community. International 
guidelines classify cases as hospital-acquired if symptom onset occurs >2 days after 
admission. This classification informs surveillance and infection control, but has not 
been verified by empirical or modelling studies. 
 
Aims: To assess current classification of C. difficile acquisition using a simulation model 
as a gold standard. 
 
Methods: We simulated C. difficile transmission in a range of hospital scenarios. We 
calculated the sensitivity, specificity and precision of classifications that use cut-offs 
ranging from 0.25 hours to 40 days. We identified the optimal cut-off that correctly 
estimated the proportion of cases that were hospital acquired and the balanced cut-off 
that had equal sensitivity and specificity.  
 
Findings: The recommended two-day cut-off overestimated the incidence of hospital-
acquired cases in all scenarios and by >100% in the base scenario. The two-day cut-off 
had good sensitivity (96%) but poor specificity (48%) and precision (52%) to identify 
cases acquired during the current hospitalisation. A five-day cut-off was balanced and a 
six-day cut-off was optimal in the base scenario. The optimal and balanced cut-offs were 
more than two days for nearly all scenarios considered (ranges four to nine days and 
two to eight days).  
 
Conclusions: Current guidelines for classifying C. difficile infections overestimate the 
proportion of cases acquired in hospital in all model scenarios. To reduce 
misclassification bias, an infection should be classified as being acquired prior to 
admission if symptoms begin within five days of admission. 
 
 
Keywords: Clostridium difficile; hospital acquired infections; surveillance definitions; 
mathematical model.  
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Introduction 
 
Since Clostridium difficile was identified as the causative agent for pseudomembranous 
colitis in the late 1970s [1], awareness of the pathogen has grown, as has the burden of 
disease [2]. In 2011, there were an estimated 453,000 C. difficile infections (CDIs) and 
29,300 deaths in the United States of America alone [3]. Today C. difficile is implicated 
as the cause of 71% of hospital-associated gastrointestinal infections [4]. 
Most CDI cases are observed in healthcare facilities, but there is increasing recognition 
of community acquired cases [5]. Symptomatic individuals have mild to severe diarrhoea 
but patients may also carry the pathogen asymptomatically for weeks or months [6,7]. 
Because of the potentially long incubation period [8], patients displaying symptoms for 
the first time in a healthcare facility may have acquired the pathogen prior to admission, 
obscuring the source of transmission. 
The Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases 
Society of America (IDSA) have published recommendations for classification of CDIs [9] 
(Figure 1). They recommend that CDIs with onset of symptoms more than two days after 
admission to a healthcare facility but prior to discharge be classified as healthcare 
facility-onset, healthcare facility-associated infections. The recommendation is not 
evidence-based, but intended to be used as a standard for comparison between 
healthcare facilities and systems. The classification (or a minor variant) is used to 
estimate the relative contribution of hospital and community based transmission [3,10], 
report temporal changes in incidence [11], compare the incidence of hospital-acquired 
cases before and after interventions [12], and as a case definition for studies comparing 
hospital-acquired and community-acquired cases [10]. Therefore, it is important that 
the classification is fit for purpose, i.e. correctly estimates the number of cases that are 
hospital or community acquired and/or sufficiently discriminates between the two 
groups. 
Individuals may be colonised with C. difficile for longer than two days before showing 
symptoms. One study found the median incubation period was 19 days [13]. Another 
found that the first quartile and median delays from admission to onset of symptoms 
were eight days and 17 days respectively [10]. We hypothesise that increasing the cut-
off beyond two days will reduce sensitivity, but greatly improve specificity to identify 
hospital onset, healthcare facility associated CDI. 
We modelled C. difficile transmission in a healthcare setting to simulate the interaction 
of pathogen and patient from admission through to discharge. The model has been 
previously shown to reproduce hospital-level outcomes such as the proportions of 
infections occurring within 72 hours of admission [14]. We use this model to assess the 
current guidance for CDI and identify potential improvements to the method of 
classification. 
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Methods 
 
Mathematical Model 
A detailed description of the model can be found elsewhere [14]. Briefly, we used a 
stochastic compartmental model of C. difficile transmission in a hospital. The model 
divides admitted patients into fifteen compartments based on immune responses to C. 
difficile toxins (immune, naïve or immunocompromised), C. difficile colonisation status 
(negative, colonised or overgrowth with substantial toxin load) and the status of 
commensal gut flora (normal or disturbed). Our model simulates the time-course of 
hospitalised individuals, capturing their state from admission to discharge, including 
exposure to antimicrobials, colonisation with C. difficile, onset of CDI, treatment and 
development of immune responses (Figure 2). We considered settings where mean 
incidence of CDI is constant and therefore we assumed a constant force of colonisation, 
allowing us to use the individual Markov chain approximation described in previous 
work [14] to classify CDI origin. This allowed us to estimate the probability distribution 
of patient outcomes at the individual level (e.g. probability that a patient colonised at 
admission did not develop symptoms within two days of admission, but did develop 
symptoms prior to discharge) without running individual-based simulations. 
Case definitions for origin of infection 
Though our model simulates recurrent CDI, we considered only the first period of CDI 
experienced by patients during their hospitalisation. All estimates of incidence and 
classification were performed for this first CDI episode only. The scope of our model was 
limited to hospitalised patients so we could not consider any periods of CDI preceding or 
following the simulated hospitalisation. We therefore were unable to assess the 
classification of patients by history of recent hospitalisation and instead focused on 
events occurring during a single hospitalisation. An infection was considered previously 
acquired (PA-CDI) if the patient was colonised at admission and was continuously 
colonised until the onset of symptoms, including where patients had symptoms on 
admission. This definition necessarily included all community-acquired cases, but also 
included cases where the infection was acquired during a previous hospitalisation. All 
other CDIs were considered hospital acquired in the current hospitalisation (HACH-CDI). 
This included CDIs where the patient was not colonised at admission and CDIs where the 
patient cleared their initial colonisation and was re-colonised in hospital prior to the 
onset of symptoms. We used these definitions and our model to calculate the 
distribution of time between admission and onset of symptoms for HACH-CDI and PA-
CDI. 
Assessing the classification of origin of infection by time since admission 
We assessed the classification of cases using the time between admission and onset of 
symptoms, emulating the first step in the IDSA and SHEA recommendations (Figure 1). 
For a two-day cut-off, all CDIs with onset of symptoms before the cut-off were classified 
as PA-CDI, with all remaining CDIs classified as HACH-CDI. We calculated the incidence of 
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CDIs classified as HACH-CDI or PA-CDI and the proportions of these that were correctly 
and incorrectly classified by comparison to the true history of individuals in the model. 
To identify potential improvements to the classification, we repeated this process for 
different cut-off times from 0.01 to 40 days. 
It is common to design binary classification systems so that they balance sensitivity (the 
proportion of ‘positives’ correctly classified) and specificity (the proportion of 
‘negatives’ correctly classified). We identified the cut-off that achieves this and called it 
the ‘balanced’ cut-off. However, such classifications misclassify larger numbers of 
individuals from the majority class than from the minority class, overestimating the 
incidence of the latter. Therefore, we also determined the ‘optimal’ cut-off time that 
balanced sensitivity with precision (the proportion of individuals classified ‘positive’ that 
are actually ‘positive’). Using this cut-off there was one incorrectly classified PA-CDI for 
each incorrectly classified HACH-CDI, and the total numbers of cases classified as either 
HACH-CDI or PA-CDI were equal to the true numbers of HACH-CDI or PA-CDI cases.  
To determine whether PA-CDI and HACH-CDI cases could be differentiated by the time 
from admission to onset of symptoms, we calculated the concordance probability, 
which is the probability that the time since admission to onset of symptoms would be 
greater in a randomly chosen HACH-CDI than a randomly chosen PA-CDI. 
Sensitivity Analysis 
The parameter values for the base scenario, which reflected a moderate CDI incidence 
setting, was chosen based on previous work [14]. Sensitivity analysis has shown that the 
two most influential parameters are those governing the person-to-person transmission 
rate and the mean length of stay for patients admitted overnight. In addition, the 
proportion colonised at admission and the mean time for C. difficile overgrowth to occur 
in colonised patients with disturbed gut flora were identified as factors likely to have a 
significant impact on incidence or the time-course of infection and therefore affect the 
classification of CDIs. We calculated the balanced and the optimal cut-off times and the 
concordance probability, varying each of these parameters independently. 
Results 
 
In the base scenario, the recommended two-day cut-off had good sensitivity but poor 
specificity to identify CDI acquired in the current hospitalisation (Figure 3), 
overestimating the proportion of CDIs acquired in the current hospitalisation by nearly 
100% (Figure 4). Longer cut-offs decreased the sensitivity but increased specificity to 
identify CDI acquired in the current hospitalisation. A five-day cut-off was balanced and 
a six-day cut-off was optimal (Figure 3). 
Symptom onset for previously acquired cases was generally closer to the time of 
admission than cases acquired during the current hospitalisation. The concordance 
probability – the probability that the time from admission to onset of symptoms was 
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shorter in a random previously acquired CDI than in a random CDI acquired in the 
current hospitalisation – was 0.842 in the base scenario. This result was insensitive to 
the assumptions about the hospital setting, falling between 0.83 and 0.88 for all 
parameter values considered in the sensitivity analysis (Supp. Figure 1) 
The optimal and balanced cut-off times depended on the characteristics of the hospital 
setting and our assumption about the rate at which C. difficile overgrowth occurs in 
colonised patients (Figure 5). In our sensitivity analysis, the optimal cut-off time was 
most sensitive to the person-to-person transmission rate while the balanced cut-off 
time was most sensitive to the mean length of stay. Both the optimal and balanced cut-
offs were somewhat sensitive to the mean time to C. difficile overgrowth. The optimal 
cut-off was longest in settings with little person-to-person transmission, while the 
balanced cut-off was longest in settings with longer mean length of stay. Both the 
optimal and balanced cut-offs were longer when C. difficile overgrowth was assumed to 
develop more slowly.  
A two-day cut-off was not optimal for any of the scenarios considered. No cut-off time 
was optimal for all scenarios; however some cut-offs resulted in only moderate over- or 
under-estimation of for a wide range of parameters (Figure 5). A cut-off of 
approximately 5.5 days did not overestimate or underestimate incidence of hospital 
acquired or previously acquired CDI by more than 20% for a wide range of mean times 
to C. difficile overgrowth (1-9 days), proportion colonised at admission (0.1-15%), mean 
length of stay (3-16 days) and rate of person-to-person transmission (0.075-0.14). In our 
sensitivity analysis, the scenario with the shortest optimal cut-off (3.6 days) was the 
scenario with very high person-to-person transmission (0.18). This extreme scenario had 
double the person-to-person transmission of the base scenario, and resulted in 45 
hospital-acquired CDIs per 10,000 patient-days. 
The classification error of a two-day cut-off was much higher in settings with less 
person-to-person transmission and substantially higher in settings with shorter mean 
length of stay (Supp. Figure 2). If transmission was set to 33% of the base rate, a two-
day cut-off overestimated the incidence of CDI acquired in the current hospitalisation by 
over 350%. Even a six-day cut-off overestimated the incidence by 100% in this low-
transmission setting. However the balanced cut-off was only slightly higher in a low 
incidence setting (5.0 days) than in a high incidence setting (4.9 days). 
Discussion 
 
Time from admission to onset of symptoms is a reasonable measure for discriminating 
CDIs acquired in the current hospitalisation from previously acquired CDIs. IDSA and 
SHEA recommend a cut-off of two days for the classification of hospital onset CDIs as 
community or hospital acquired. This cut-off systematically overestimates the 
proportion of CDIs that are acquired in the current hospitalisation and underestimates 
the proportion that is acquired prior to admission. Since all community acquired CDIs 
observed in healthcare settings must be acquired prior to admission, the current 
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guidelines may also systematically underestimate the proportion of cases that are 
community acquired. Moreover, the low specificity of the two-day cut-off for identifying 
hospital acquired cases may cause significant misclassification bias in studies that 
compare hospital and community acquired cases, reducing apparent differences 
between the two groups. 
Since our model did not differentiate strains of C. difficile, our definition of previously 
acquired CDI does not exclude patients that were colonised at admission but 
subsequently acquired an additional strain of C. difficile prior to the onset of symptoms. 
This is unlikely to represent a significant portion of previously acquired CDIs [15] and so 
is unlikely to affect our recommendations. The structure and parameter values in our 
model synthesises the peer review literature on hospital associated CDIs [14], and is not 
fitted to a single data set. However, our key finding, that the standard classification of 
CDIs overestimates the proportion of cases acquired in the current hospitalisation, is 
robust to very large variations in all parameters. 
There is a large variation in mean hospital length-of-stay worldwide. Within the OECD, 
mean lengths of stay range between 3.9 days (Turkey) and 17.2 days (Japan) [16]. Our 
recommended optimal cut-off is sensitive to the mean length of stay but a cut-off of five 
days performs well over this entire range. In contrast, a cut-off of two days consistently 
overestimates the incidence of CDI acquired in the current hospitalisation and 
overestimates the incidence of CDI acquired in the current hospitalisation by more than 
100% when the mean length of stay is less than six days. 
The rate of person-to-person transmission is difficult to measure directly and is likely to 
vary significantly between settings due to differences in hygiene protocols and 
adherence to these protocols. The degree of person-to-person transmission in our base 
scenario was estimated from hospitals with high incidence of CDI (28.1 cases per 10,000 
patient days) [14,17], and therefore may lie in the upper end of the plausible range. The 
optimal cut-off is longer in settings with less person-to-person transmission. Therefore, 
in many settings – especially those that have effective infection control programs – an 
even longer cut-off may be required to avoid overestimating the incidence of CDI 
acquired in the current hospitalisation. Since it is not usually possible to estimate the 
rate of person-to-person transmission without knowing the incidence of hospital 
acquired infection and colonisation, and most estimates of the incidence of hospital 
acquired cases are based on the very classification scheme we are assessing, in practice 
we cannot calculate the optimal cut-off for a given setting. However, a five-day cut-off 
balances sensitivity and specificity independent of the rate of person-to-person 
transmission and is approximately optimal for a range of transmission rates.    
IDSA and SHEA also recommend that only those cases arising >84 days (12 weeks) after 
the most recent hospital discharge should be classified as community acquired [9]. This 
recommendation may also lead to systematic misclassification, with the extent of 
misclassification determined by the choice of cut-off. However, the scope of our model 
was limited to hospitalised patients so we could not consider any periods of CDI or 
asymptomatic colonisation preceding or following simulated hospitalisations. Therefore 
we are unable to make recommendations for the optimal use of a patient’s history of 
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hospitalisation to classify the origin of CDI for either community onset or hospital onset 
CDI. This classification should also be assessed with empirical studies or models that 
simulate patients in communities and hospitals. 
It is difficult to determine the source of transmission for CDI cases, and so assess 
classification by time since admission empirically. Since the same strains of C. difficile 
circulate in hospitals and communities, cases cannot be distinguished by strain type 
alone [18,19]. Whole genome sequencing can identify transmission events, but the most 
comprehensive studies have not sequenced isolates from many asymptomatic carriers, 
and have not been able to identify a transmission source for ≥75% of all infections 
[8,18]. Screening all admissions for asymptomatic colonisation, coupled with contact 
precautions and antimicrobial stewardship for colonised patients, may reduce the 
incidence of CDI [12,20]. Consequently, studies where screening has occurred may not 
be representative and thus unsuitable for assessing classification of the origin of 
infections in settings without screening. Therefore, modelling based approaches may be 
the best means for assessing the classification of CDIs. 
Our findings add to a growing body of evidence that suggests transmission and 
reservoirs of C. difficile outside hospitals are as least as important as within-hospital 
transmission. Detailed surveillance has found the same strains circulating in 
communities and hospitals, demonstrating the interconnectedness of the two 
populations [18,19]. Further, modelling studies have shown the reproduction number 
(the number of secondary colonisations arising from a typical primary colonisation in a 
population of susceptible individuals) is less than one in many healthcare settings, 
suggesting that CDI is sustained primarily by the admission of colonised individuals, not 
within-hospital transmission [14,21]. Moreover, only 19% [18] of all CDIs and 25% [8] of 
CDIs in hospitals can be reasonably attributed to transmission from symptomatic 
inpatients, with the remainder acquired from asymptomatic carriers or sources in the 
community. While hospital onset CDIs are carefully monitored and reported, community 
onset CDIs are likely to be underreported – especially in patients who have not been 
hospitalised recently [22,23].  
Standardised definitions and reporting of hospital acquired C. difficile infections have 
value, but the current two-day cut-off is not based on strong evidence and 
overestimates the proportion of cases acquired during the current hospitalisation. 
Though it may be difficult to change reporting standards, adopting a five-day or six-day 
cut-off will improve the classification of potential sources of infection for C. difficile, 
recognising the key role of CDI acquired prior to hospital admission, including 
community-acquired cases. 
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Figure Captions  
 
Figure 1 Classification of CDIs recommended by the Society for Healthcare Epidemiology 
of America (SHEA) and the Infectious Diseases Society of America (IDSA) with a 
comparison to the definitions of previously acquired (PA) and hospital acquired in 
current hospitalisation (HACH) used in the model. 
Figure 2 Diagram summarising the main states and events simulated in the model. 
Admitted patients can be in any of the above states, and may change states throughout 
their hospitalisation.  Each of the five states is further divided according immunity to C. 
difficile toxins. Only patients with disrupted intestinal flora and C. difficile overgrowth 
but no immunity to toxins are symptomatic for CDI, however all C. difficile positive 
patients with disrupted intestinal flora are infectious. 
Figure 3 Sensitivity, specificity and precision of identifying CDIs acquired in the current 
hospitalisation by time since admission. Results are shown for the base scenario only. 
Sensitivity and specificity are equal with a five-day cut-off. The optimal cut-off (equal 
sensitivity and precision) is longer at 5.9 days.  
Figure 4 Classification of the origin of CDI by time since admission for selected cut-offs, 
in the base scenario. Shorter cut-offs detect most cases acquired in the current 
hospitalisation but misclassify many previously acquired cases, overestimating the 
proportion of CDIs that are acquired in the current hospitalisation. A cut-off of six days 
overestimates neither. 
Figure 5 The effect of four parameters on the optimal (light blue – equal sensitivity and 
precision) and balanced (brown – equal sensitivity and specificity) cut-off times for 
classifying the origin of CDI by time since admission to onset of symptoms. Light blue 
dashed curves indicate range of cut-offs that over/underestimate the incidence of 
previously acquired CDIs and CDIs acquired in the current hospitalisation by ≤20%. The 
vertical dashed lines mark the values of the parameters in the base scenario. 
